Click here to jump to the main content
Home
News and Updates
National Drug Policy
Strategies & Action Plans
Committees
Alcohol
Tobacco
Cannabis
Party Pills
Other Drugs
Publications
Contact Us
National Drug Policy New Zealand
Health Committees
|
Accessibility
|
Site Index
|
Contact Us
Search:
Print this
Email this
Publications
Buprenorphine in New Zealand 2007 Strategic Assessment
Date of publication: April 2008
Buprenorphine is a strong synthetic opioid analgesic. It has properties similar to opium and therefore morphine salts. In isolation buprenorphine appears to be a safer drug than related strong opioids due to its mild opioid antagonistic properties.
This paper was discussed by the Expert Advisory Committee on Drugs a their meeting on the 29 November 2007
Document availability
This publication is available in PDF format.
Buprenorphine in New Zealand 2007 Strategic Assessment (PDF, 191 KB)
Legal
|
newzealand.govt.nz
|
Minister of Health